You are here: Industry Insights > Tumor

News List

NBE-Therapeutics Begins Anti-ROR1 ADC Study for Solid Tumors americanpharmaceuticalreview
October 30, 2020
NBE-Therapeutics has commenced first-in-human studies of its lead program NBE-002 targeting ROR1, for triple negative breast cancer (TNBC) and other solid tumors.
BioEclipse Receives FDA Clearance of CRX100 IND Application americanpharmaceuticalreview
April 30, 2020
BioEclipse Therapeutics announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for the Company's lead drug candidate, CRX100.
CAR macrophages go beyond T cells to fight solid tumors worldpharmanews
March 25, 2020
Chimeric antigen receptor (CAR) T cell therapy has been a game-changer for blood cancers but has faced challenges in targeting solid tumors.
Gut bacteria can penetrate tumors and aid cancer therapy worldpharmanews
March 10, 2020
Researchers at the University of Texas Southwestern Medical Center and University of Chicago have discovered that bacteria that usually live in the gut can accumulate in tumors and improve the effectiveness of immunotherapy in mice.
AI Might Help Spot, Evaluate Prostate Cancer drugs
January 17, 2020
In another step toward using artificial intelligence in medicine, a new study shows that computers can be trained to match human experts in judging the severity of prostate tumors.
Surgery May Add Years for Patients With Deadly Brain Cancer drugs
January 16, 2020
Surgical removal of the entire tumor may extend the lives of patients with a rare and deadly type of brain cancer called brainstem high-grade gliomas, a new study suggests.
FDA approves the first targeted therapy to treat a rare mutation in patients with gastrointestinal stromal tumors worldpharmanews
January 14, 2020
The U.S. Food and Drug Administration approved Ayvakit (avapritinib) for the treatment of adults with unresectable (unable to be removed with surgery) or metastatic (when cancer cells spread to other parts of the body) gastrointestinal stromal tumor (GIST
Aspirin appears to curb colorectal cancer recurrence and tumor growth worldpharmanews
January 09, 2020
The benefits of a daily aspirin may extend beyond heart health to colorectal cancer treatment, say City of Hope researchers who have found aspirin appears to reduce tumor growth and ...
Agenus Commences Phase 1 Trial with AGEN1223 americanpharmaceuticalreview
January 09, 2020
Agenus announced the dosing of the first patient with AGEN1223. AGEN1223 is a novel bi-specific antibody discovered by Agenus and designed to deplete regulatory T cells in the tumor microenvironment.
AI Beat Humans in Spotting Breast Tumors drugs
January 06, 2020
Machines can be trained to outperform humans when it comes to catching breast tumors on mammograms, a new study suggests.Researchers at Google and several universities are working on an artificial intelligence (AI) model aimed at ...

Previous page 1 2 3 4 5 6 7 Next page